AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer

Despite the use of 5-fluorouracil (5-FU)-based adjuvant treatments, a large proportion of patients with high-risk stage II/III colorectal cancer will relapse. Thus, novel therapeutic strategies are needed for early-stage colorectal cancer. Residual micrometastatic disease from the primary tumor is a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2014-01, Vol.20 (1), p.164-175
Hauptverfasser: DUNNE, Philip D, MCART, Darragh G, REDMOND, Keara, LONGLEY, Daniel B, SALTO-TELLEZ, Manuel, JOHNSTON, Patrick G, VAN SCHAEYBROECK, Sandra, BLAYNEY, Jaine K, KALIMUTHO, Murugan, GREER, Samanda, TINGTING WANG, SRIVASTAVA, Supriya, CHEE WEE ONG, ARTHUR, Ken, LOUGHREY, Maurice
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!